Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

Pulmonary arterial hypertension (PAH) is characterized by progressive pulmonary artery
remodelling leading to increased right ventricular pressure overload, which results in right …

Pulmonary arterial hypertension (PAH) is a severe disease with a resultant increase of the
mean pulmonary arterial pressure, right ventricular hypertrophy and eventual death …

Until 20 years ago the treatment of pulmonary arterial hypertension (PAH) was based on
case reports and small series, and was largely ineffectual. As a deeper understanding of the …

Pulmonary arterial hypertension (PAH) is a fatal disease characterized by vascular
remodeling and chronic inflammation. Macrophages are the key orchestrators of …

Pulmonary arterial hypertension (PAH) is a disease characterized by progressive
remodeling of the distal pulmonary arteries, resulting in the loss of vascular cross-sectional …

Pulmonary arterial hypertension (PAH) is a fatal disease associated with vasoconstriction
and vascular remodelling. There are three well-known pathways that contribute to the …

Pulmonary arterial hypertension (PAH) is characterized by remodelling of pulmonary
arteries caused by a proliferation/apoptosis imbalance within the vascular wall. This …

Despite recent therapeutic advances, pulmonary hypertension (PH) remains a fatal disease
due to the development of right ventricular (RV) failure. At present, no treatments targeted at …

Pulmonary arterial hypertension (PAH) is a devastating disorder characterized by abnormal
increased vasoconstriction and vascular remodelling. In this review we discuss the …